Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significanceMichael Boyiadzis(UPMC Hillman Cancer Center), Michael Bishop(University of Chicago)Journal for ImmunoTherapy of CancerDecember 1, 201810.1186/s40425-018-0460-5Cited by 246SaveCiteExport RISWatch citationsRelated PapersBlast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1|Haematologica|2011|411